These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2529016)
1. The binding of (+)-isradipine by guinea-pig intact atria. Herzig S; Lüllmann H Br J Pharmacol; 1989 Aug; 97(4):1246-50. PubMed ID: 2529016 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of myocardial Ca2+ channels by three dihydropyridines with different structural features: potential-dependent blockade by Ro 18-3981. Holck M; Osterrieder W Br J Pharmacol; 1987 May; 91(1):61-7. PubMed ID: 2439160 [TBL] [Abstract][Full Text] [Related]
3. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes. Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031 [TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Wei XY; Rutledge A; Triggle DJ Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561 [TBL] [Abstract][Full Text] [Related]
5. Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. Cohen CJ; Spires S; Van Skiver D J Gen Physiol; 1992 Oct; 100(4):703-28. PubMed ID: 1281221 [TBL] [Abstract][Full Text] [Related]
6. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes. Kamp TJ; Sanguinetti MC; Miller RJ J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670 [TBL] [Abstract][Full Text] [Related]
7. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964 [TBL] [Abstract][Full Text] [Related]
8. (+)-isradipine but not (-)-Bay-K-8644 exhibits voltage-dependent effects on cat adrenal catecholamine release. López MG; Michelena P; Gandía L; García AG Br J Pharmacol; 1991 Feb; 102(2):289-96. PubMed ID: 1707711 [TBL] [Abstract][Full Text] [Related]
9. (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. Boer R; Grassegger A; Schudt C; Glossmann H Eur J Pharmacol; 1989 May; 172(2):131-45. PubMed ID: 2548881 [TBL] [Abstract][Full Text] [Related]
10. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery. Morel N; Godfraind T Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351 [TBL] [Abstract][Full Text] [Related]
11. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Bellemann P; Ferry D; Lübbecke F; Glossman H Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299 [TBL] [Abstract][Full Text] [Related]
12. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations. Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235 [TBL] [Abstract][Full Text] [Related]
13. Characterization of binding sites for two classes of calcium channel antagonists in human forebrain. Quirion R Eur J Pharmacol; 1985 Oct; 117(1):139-42. PubMed ID: 2935407 [TBL] [Abstract][Full Text] [Related]
14. Interactions of spironolactone with (+)-[3H]-isradipine and (-)-[3H]-desmethoxyverapamil binding sites in vascular smooth muscle. Mironneau J; Sayet I; Rakotoarisoa L; Dacquet C; Mironneau C Br J Pharmacol; 1990 Sep; 101(1):6-7. PubMed ID: 2149292 [TBL] [Abstract][Full Text] [Related]
15. Binding of [3H]isradipine (PN 200-110) on smooth muscle cell membranes from different bovine arteries. Pinquier JL; Urien S; Chaumet-Riffaud P; Comte A; Tillement JP J Cardiovasc Pharmacol; 1988 Apr; 11(4):402-6. PubMed ID: 2453742 [TBL] [Abstract][Full Text] [Related]
16. Interactions of cryptosin with mammalian cardiac dihydropyridine-specific calcium channels. Rao VR; Banning JW Life Sci; 1990; 47(18):1667-76. PubMed ID: 2174493 [TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand. Ferry DR; Goll A; Glossmann H Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422 [TBL] [Abstract][Full Text] [Related]
18. Selective antagonism of calcium channel activators by fluspirilene. Kenny BA; Fraser S; Kilpatrick AT; Spedding M Br J Pharmacol; 1990 Jun; 100(2):211-6. PubMed ID: 1696149 [TBL] [Abstract][Full Text] [Related]
19. Effects of oxodipine and elgodipine on (+)-[3H]-isradipine binding to cardiac and vascular membranes: cardiovascular selectivity. Rakotoarisoa L; Leprêtre N; Mironneau J; Galiano A; Mironneau C Fundam Clin Pharmacol; 1994; 8(6):546-52. PubMed ID: 7721232 [TBL] [Abstract][Full Text] [Related]
20. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells. Greenberg DA; Carpenter CL; Messing RO J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]